The Role of Enzalutamide in HR+ Advanced Breast Cancer

December 16, 2017
Denise Yardley, MD

Denise Yardley, MD, Senior Investigator, Sarah Cannon Research Institute, discusses the role of enzalutamide in hormone-receptor positive (HR+) advanced breast cancer.